Fortetropin in geriatric and senior dogs with reduced mobility
A randomized, double-blinded, placebo-controlled study evaluated Fortetropin, a freeze-dried fertilized egg yolk product, on mobility in senior dogs, motivated by age-related muscle atrophy and osteoarthritis pain. Mobility was scored with the owner-completed LOAD questionnaire. The treatment group showed mild but statistically significant improvement from baseline at weeks 6 and 12, whereas the placebo group did not improve and there was no significant difference between treatment and placebo groups.
Record
| Design | randomized controlled trial |
|---|---|
| Status | completed |
| Intervention | Fortetropin, a nonthermal-pasteurized, freeze-dried, fertilized egg yolk product |
| Intervention class | diet or supplement |
| Comparator | Placebo |
| Duration | 12 weeks (mobility scores at week 6 and week 12) |
| Age | senior dogs |
| Other | geriatric and senior dogs with reduced mobility |
| Primary outcome | Mobility scores from the Liverpool Osteoarthritis in Dogs (LOAD) questionnaire |
| Result (as reported) | Mild, but statistically significant, improvement of the mobility scores for the treatment group at both week 6 (P = 0.03) and week 12 (P = 0.006) compared to the baseline score. No statistical improvement was noted at any time in the placebo group or between the treatment and placebo group. |
| Tags | supplement, mobility, sarcopenia, fortetropin, load |
Notes: No full text in the corpus: number of dogs, dose and setting are not stated in the abstract. The client-based LOAD survey implies owner-assessed dogs. P values are quoted around inline italic tags in the abstract.
Sources and verbatim quotes
Evaluation of Fortetropin in geriatric and senior dogs with reduced mobility. (2022) PMID 36185794 (results)
As pets age, quality of life and mobility can be affected by pain of osteoarthritis and age-related muscle atrophy (sarcopenia).
The purpose of this randomized, double-blinded, placebo-controlled study was to evaluate the effects of Fortetropin, a nonthermal-pasteurized, freeze-dried, fertilized egg yolk product, on mobility in senior dogs.
Mobility scores were calculated using a standardized and validated client-based survey: the Liverpool Osteoarthritis in Dogs (LOAD) questionnaire.
Results showed mild, but statistically significant, improvement of the mobility scores for the treatment group at both week 6
= 0.03) and week 12 (
= 0.006) compared to the baseline score. No statistical improvement was noted at any time in the placebo group or between the treatment and placebo group.
Reproduce: canine_trial_search(trial_id="fortetropin-senior-dogs-mobility-rct-2022") in dog-geroscience-mcp; dataset canine-trial-registry.